Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
Managing Disability in Progressive Multiple Sclerosis.
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.
Multitasking in Multiple Sclerosis: Can it Inform Vocational Functioning?
Is the 'liberation procedure' for multiple sclerosis really liberating?
White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Exercise training improves depressive symptoms in people with multiple sclerosis: Results of a meta-analysis.
Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
The need for randomization in animal trials: an overview of systematic reviews.
Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity.
Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
(P150) assessment of acute and late toxicities of intracranial stereotactic radiosurgery in multiple sclerosis patients.
[Sympathetic skin response and multiple sclerosis: Descriptive and prospective study, and association with neuroperineal disorders].
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Bladder dysfunction and quality of life for people with multiple sclerosis.
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
Pages
« first
‹ previous
…
525
526
527
528
529
530
531
532
533
…
next ›
last »